Literature DB >> 17044296

The surgical approach for radiofrequency ablation of liver tumors.

Guido Schumacher1, Robert Eisele, Antonino Spinelli, Peter Neuhaus.   

Abstract

Radiofrequency ablation for the treatment of liver tumors is one of the best alternative treatment modalities when surgical resection is not possible. To find the right indication for the treatment, every patient should be treated in a high-volume center for the treatment of liver tumors in an interdisciplinary conference consisting of liver surgeons, interventional radiologists, medical oncologists, and gastroenterologists. With a multimodal approach including anatomic segmental and wedge resection of the liver, RFA, and chemotherapy, a median survival of 36 months was achieved in technically unresectable patients with colorectal liver metastases (Elias et al. 2005). This survival doubles the survival rate of any other treatment modality in this group of patients. These interdisciplinary conferences also serve to determine the approach for RFA, whether it should be percutaneous, laparoscopic, or open surgery. The safest ablation with the fewest adverse events from RFA is the open surgical approach, followed by the laparoscopic approach. The approach with the highest risk of injury to organs in proximity to the liver is the percutaneous approach. Therefore, many variables must be evaluated before making definite decisions. After choosing RFA as the best alternative treatment option after evaluation of all variables for a particular patient, it offers a treatment option with a potential cure. A major advantage is the possible combination with liver resection, which extends the indication for surgical or ablative therapy.

Entities:  

Mesh:

Year:  2006        PMID: 17044296     DOI: 10.1007/3-540-28137-1_4

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  2 in total

Review 1.  Complications of intraoperative radiofrequency ablation of liver metastases.

Authors:  Tsiriniaina Razafindratsira; Milène Isambert; Serge Evrard
Journal:  HPB (Oxford)       Date:  2010-12-07       Impact factor: 3.647

2.  Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors.

Authors:  John Eriksson; Peter Stålberg; Anders Nilsson; Johan Krause; Christina Lundberg; Britt Skogseid; Dan Granberg; Barbro Eriksson; Göran Akerström; Per Hellman
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.